drugset / Trial / NCT01966276

The Synergy Trial: Methylphenidate Plus a CFS-Specific Nutrient Formula as a Treatment for Chronic Fatigue Syndrome

NCT01966276

Phase 2 Unknown 134 enrolled K-PAX Pharmaceuticals, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The Synergy Trial will evaluate the safety and efficacy of a currently available medication (methylphenidate hydrochloride) combined with a CFS-specific dietary supplement (CFS Nutrient Formula) to treat Chronic Fatigue Syndrome (CFS).

Timeline

Start
2013-11
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject CFS Nutrient Formula Other / unclassified
Subject Methylphenidate Small molecule 10 mg